MyFinsight
Home
Blog
About
Airsculpt Technologies, Inc. (AIRS)
Airsculpt Technologies, Inc. (AIRS)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$2,134K
Free Cash flow
-$1,466K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from public offerings, ...
Depreciation and amortization
Equity-based compensation
Others
Negative Cash Flow Breakdown
Payments on term loans
Net loss
Accrued and other liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-1,112
-2,397
1,283
-9,512
Depreciation and amortization
2,941
3,021
3,076
3,217
Equity-based compensation
912
559
-1,385
1,125
Non-cash interest expense amortization of debt costs
137
136
147
136
Deferred income taxes
-
-
-5,914
-
Loss on impairment of long-lived assets
0
-
11,820
-7,137
Cost related to closing location
-
-
-2,152
-
Taxes receivable
388
475
-1,958
1,653
Prepaid expense and other current assets
868
158
2,267
1,582
Other assets
818
-1,188
981
-2,732
Accounts payable
-209
2,112
919
1,121
Deferred revenue and patient deposits
-752
2,029
1,024
-241
Accrued and other liabilities
-1,081
-744
127
-2,705
Net cash provided by operating activities
-1,238
5,271
-2,531
-225
Purchases of property and equipment, net
228
51
58
180
Net cash used in investing activities
-228
-51
-58
-180
Payments on term loans
1,385
11,365
910
910
Payments for debt modification
0
0
105
51
Payments on revolving credit facility
0
-
-10,000
0
Proceeds from public offerings, net
4,975
14,591
4,996
-240
Distribution to member
-
-
0
-
Dividends paid to shareholders
-
-
0
0
Payment of taxes withheld through vested equity-based compensation
0
195
0
0
Other financing activity
10
-10
1,652
-1,178
Net cash provided by/(used in) financing activities
3,600
3,021
5,633
-2,379
Net increase/(decrease) in cash and cash equivalents
2,134
8,241
3,044
-2,784
Beginning of period
16,690
8,449
5,405
8,235
End of period
18,824
16,690
8,449
5,405
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from public
offerings, net
$4,975K
(-64.48%↓ Y/Y)
Other financing
activity
$10K
(102.11%↑ Y/Y)
Net cash provided
by/(used in) financing...
$3,600K
(196.46%↑ Y/Y)
Canceled cashflow
$1,385K
Net
increase/(decrease) in cash and cash...
$2,134K
(4739.13%↑ Y/Y)
Canceled cashflow
$1,466K
Payments on term loans
$1,385K
(-88.43%↓ Y/Y)
Depreciation and
amortization
$2,941K
(-54.67%↓ Y/Y)
Equity-based compensation
$912K
(-64.80%↓ Y/Y)
Non-cash interest
expense amortization of...
$137K
(-43.39%↓ Y/Y)
Net cash provided by
operating activities
-$1,238K
(-121.16%↓ Y/Y)
Net cash used in
investing activities
-$228K
(89.47%↑ Y/Y)
Canceled cashflow
$3,990K
Net loss
-$1,112K
(67.66%↑ Y/Y)
Accrued and other
liabilities
-$1,081K
(74.31%↑ Y/Y)
Purchases of property and
equipment, net
$228K
(-89.47%↓ Y/Y)
Prepaid expense and
other current assets
$868K
(46.87%↑ Y/Y)
Other assets
$818K
(116.63%↑ Y/Y)
Deferred revenue and
patient deposits
-$752K
(-1466.67%↓ Y/Y)
Taxes receivable
$388K
(131.02%↑ Y/Y)
Accounts payable
-$209K
(85.69%↑ Y/Y)
Buy us a coffee